Navigation Links
Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas
Date:9/17/2007

NEW YORK, Sept. 17 /PRNewswire/ -- iiBIG's New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies conference is scheduled for October 29-30, 2007, at the Flamingo in Las Vegas, Nevada. The sessions will cover developments in controlled release technologies, nanobiomedicine, siRNa, protein delivery platforms, liposome drug delivery, tumor targeting and other novel applications for oral/nasal/transdermal/injectable and other systemic drug absorption platforms.

The program agenda will feature 2 tracks focusing on cutting-edge science and new technologies and licensing and commercialization strategies. A sampling of topics includes:

-- Future Advances and Developments in Drug Delivery Nanotechnology

-- Deal Structuring Strategies - University Technology Licensing and

Partnerships

-- The History of Controlled Release Systems from the 1960s to the

Present, and their Evolution from Macro to Micro to Nano Scale DDS

-- Combination Products Delivering Insulin

-- Matrix Effects on Monoclonal Antibodies

-- Sustained Delivery of Drugs with DepoFoam(R) Multivesicular Liposomes

-- FDA Patents - Case Study of Transdermal Patches

-- Advances in Oral Delivery Strategies for Vaccines

-- Transdermal Solutions for Therapeutic Applications- New Science to

Bring to Market

-- Rapid Clinical Evaluation of Drug Delivery Technologies

-- Innovation and Success Strategies - Learning and Un-learning from key

players

For complete agenda details, visit: http://www.iibig.com/P0704

An impressive list of chief scientific officers, principal scientists and savvy business development and deal-making experts from a number of biotechnology, drug delivery and specialty pharmaceutical companies are scheduled to present. They include:

-- Erkki Ruoslahti, MD, PhD, Distinguished Professor, Burnham Institute

for Medical Research (at UCSB)

-- Allan S. Hoffman, Professor of Bioengineering, University of

Washington, College of Engineering

-- John S. Patton, PhD, Founder and Chief Scientific Officer, Nektar

Therapeutics

-- Igor Gonda, PhD, Chief Executive Officer, Aradigm Corporation

-- Tomas Landh, Principal Scientist, Preformulation & Delivery, Novo

Nordisk

-- Chris Rhodes, Executive Director Pharmaceutical Sciences, Amylin

-- Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam

-- Bill van Antwerp, Distinguished Scientist and Chief Technology

Officer, Medtronic

-- Gregory I. Frost, PhD, Vice President and Chief Scientific Officer,

Halozyme Therapeutics

-- Seth Feuerstein, President & CEO, Carigent Therapeutics

-- Khursheed Anwer, PhD, Vice President, Research, Expression Genetics

-- Ravi Kiron, PhD, Chief Operating Officer, LifeTech Innovations

-- Maggie Pax, Senior Director, Business Development, MicroCHIPS

-- Michael Arenberg, Executive Director, Business Development, Durect

-- Fernando Alvarez-Nunez, PhD, Principal Scientist, Small Molecule

Pharmaceutics, Amgen

-- Ashutosh Sharma, PhD, Executive Vice President, Vyteris

-- William Edelman, Chief Executive Officer, TyRx Pharma, Inc.

-- Eric Fossel, PhD, Founder & CEO, Strategic Science & Technologies LLC

-- Bill Lambert, PhD, Senior Vice President, Pharmaceutical Development,

Pacira Pharmaceuticals

-- Aaron F. Barkoff, Partner, McDonnell Boehnen Hulbert & Berghoff LLP

-- David Lechuga-Ballesteros, PhD, Senior Director, R&D, Aridis

Pharmaceuticals

-- Peter Scholes, Vice President Pharmaceutical Sciences, Pharmaceutical

Profiles Ltd

-- Mahesh V. Chaubal, PhD, M.S., Director Global R&D, Baxter

Healthcarealthcare

-- Jonathan Rigby, Vice President Marketing, Zoegenix Inc.

TECHNOLOGY SHOWCASE PANEL: If your company provides products or services to drug delivery executives and you would like to schedule a 10-15 minute presentation, showcasing opportunities are available. Contact: Kellie Swanstrom, VP, Business Development, iiBIG 973-571-0867 or kellies@iibig.com.

FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION:

Please visit: http://www.iibig.com/P0704

Call: 212-300-2523

E-mail: info@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. CIO Leadership Series: Kathi Christian, QTI Group
2. Just in time for Christmas: Retail IT.
3. Musicnotes signs licensing deal with Christian music provider
4. Carl Christensen says Marshfield Clinics history gives it an IT edge
5. An early Christmas gift
6. Christmas comes early with Treo 650
7. Nettles Names Christenson as Director of Bureau of Entrepreneurship
8. Speaker announces business members of IT Task Force
9. Eight lawmakers named to Speakers IT task force
10. What do CIOs want? Fusion2007 speakers weigh in
11. Innovation expert speaks on the business-IT balancing act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, ... require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc ... to client demand KbioBox developed a sophisticated “3 click” gene dditing off target ... from KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)... Korea , Dec. 8, 2016 Eutilex ... $21 billion KRW (US $18.9M) Series A financing. This ... Investment, G.N. Tech Venture and SNU Bio Angel. This ... to 30.5 billion KRW (US $27.7M) since its founding ... Eutilex to bolster the development and commercialization of its ...
Breaking Biology Technology:
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... Research and Markets has announced the addition of the ... their offering. ... The global bioinformatics market ... 6.21 Billion in 2016, growing at a CAGR of 21.1% during ... is driven by the growing demand for nucleic acid and protein ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
Breaking Biology News(10 mins):